Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety

The safety and efficacy of sodium‐glucose cotransporter 2 inhibitors in posttransplantation diabetes mellitus is unknown. We converted stable kidney transplant patients to 10 mg empagliflozin, aiming at replacing their insulin therapy (<40 IU/d). N = 14 participants (the required sample size) com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transplant
Main Authors: Schwaiger, Elisabeth, Burghart, Lukas, Signorini, Lorenzo, Ristl, Robin, Kopecky, Chantal, Tura, Andrea, Pacini, Giovanni, Wrba, Thomas, Antlanger, Marlies, Schmaldienst, Sabine, Werzowa, Johannes, Säemann, Marcus D., Hecking, Manfred
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590167/
https://ncbi.nlm.nih.gov/pubmed/30585690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15223
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados